A review of pragmatic trials found a high degree of diversity in design and scope, deficiencies in reporting and trial registry data, and poor indexing.

Data quality Database searching Intervention Pragmatic trials Registration Reporting Trial design

Journal

Journal of clinical epidemiology
ISSN: 1878-5921
Titre abrégé: J Clin Epidemiol
Pays: United States
ID NLM: 8801383

Informations de publication

Date de publication:
09 2021
Historique:
received: 17 08 2020
revised: 24 02 2021
accepted: 18 03 2021
pubmed: 1 4 2021
medline: 11 11 2021
entrez: 31 3 2021
Statut: ppublish

Résumé

We established a large database of trials to serve as a resource for future methodological and ethical analyses. Here, we use meta-data to describe the broad landscape of pragmatic trials including research areas, identification as pragmatic, quality of trial registry data and enrolment. Trials were identified by a validated search filter and included if a primary report of a health-related randomized trial published January 2014-April 2019. Data were collated from MEDLINE, Web of Science, ClinicalTrials.gov, and full text. 4337 eligible trials were identified from 13,065 records, of which 1988 were registered in ClinicalTrials.gov. Research areas were diverse, with the most common being general and internal medicine; public, environmental and occupational health; and health care sciences and services. The term "pragmatic" was seldom used in titles or abstracts. Several domains in ClinicalTrials.gov had questionable data quality. We estimated that one-fifth of trials under-accrued by at least 15%. There is a need to improve reporting of pragmatic trials and quality of trial registry data. Under accrual remains a challenge in pragmatic RCTs despite calls for more streamlined recruitment approaches. The diversity of pragmatic trials should be reflected in future ethical analyses.

Identifiants

pubmed: 33789151
pii: S0895-4356(21)00103-7
doi: 10.1016/j.jclinepi.2021.03.021
pmc: PMC8996736
mid: NIHMS1791998
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

45-57

Subventions

Organisme : NIA NIH HHS
ID : U54 AG063546
Pays : United States
Organisme : CIHR
ID : PJT-153045
Pays : Canada

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Références

JCO Clin Cancer Inform. 2020 Jul;4:614-622
pubmed: 32667822
N Engl J Med. 2011 Mar 3;364(9):852-60
pubmed: 21366476
JAMA. 2012 May 2;307(17):1838-47
pubmed: 22550198
Clin Trials. 2017 Aug;14(4):333-341
pubmed: 28393537
Trials. 2020 Jan 7;21(1):34
pubmed: 31910857
JAMA Intern Med. 2018 Sep 1;178(9):1278-1280
pubmed: 30039169
BMJ. 2013 Oct 29;347:f6104
pubmed: 24169943
Trials. 2019 Dec 23;20(1):765
pubmed: 31870433
BMC Health Serv Res. 2002 Sep 04;2(1):18
pubmed: 12213183
BMC Med. 2015 Nov 18;13:282
pubmed: 26581191
Med Clin (Barc). 2003 Sep 27;121(10):384-8
pubmed: 14565915
BMJ Open. 2015 Sep 25;5(9):e008932
pubmed: 26408831
J Clin Epidemiol. 2017 Sep;89:173-180
pubmed: 28502808
JAMA. 2014 Jun 18;311(23):2381-2
pubmed: 24810723
N Engl J Med. 2017 Jan 26;376(4):383-391
pubmed: 28121511
BMJ. 2019 Mar 27;364:l1092
pubmed: 30917969
BMC Med. 2018 Apr 3;16(1):49
pubmed: 29615035
Trials. 2017 Mar 14;18(1):125
pubmed: 28292317
JAMA. 2003 Sep 24;290(12):1624-32
pubmed: 14506122
Trials. 2018 Sep 27;19(1):525
pubmed: 30261933
Health Res Policy Syst. 2018 Aug 17;16(1):83
pubmed: 30119673
J Clin Epidemiol. 2019 Dec;116:18-25
pubmed: 31374332
CMAJ. 2009 May 12;180(10):998-1000
pubmed: 19372438
Value Health. 2017 Jul - Aug;20(7):902-908
pubmed: 28712619
BMJ Glob Health. 2017 Jun 10;2(2):e000314
pubmed: 29225934
J Public Health (Oxf). 2014 Mar;36(1):170-6
pubmed: 24574064
Clin Trials. 2015 Dec;12(6):557-63
pubmed: 26400874
J Clin Epidemiol. 2020 Aug;124:75-84
pubmed: 32407765
Trials. 2020 Jul 23;21(1):675
pubmed: 32703252
J Clin Epidemiol. 2009 May;62(5):495-8
pubmed: 19348975
BMC Med. 2015 Aug 14;13:189
pubmed: 26269118
N Engl J Med. 2014 Feb 20;370(8):769-72
pubmed: 24552326
Am J Kidney Dis. 2014 May;63(5):771-80
pubmed: 24315119
Clin Trials. 2018 Feb;15(1):9-16
pubmed: 29224380
Clin Trials. 2015 Feb;12(1):77-83
pubmed: 25475878
J Clin Epidemiol. 2011 Oct;64(10):1095-101
pubmed: 21474282
J Clin Epidemiol. 2020 Oct;126:193-201
pubmed: 32325221
Clin Trials. 2015 Jun;12(3):276-86
pubmed: 25733677
JAMA Netw Open. 2020 Aug 3;3(8):e2014682
pubmed: 32845329
J Clin Epidemiol. 2015 Sep;68(9):1059-67
pubmed: 25542517
J Chronic Dis. 1967 Aug;20(8):637-48
pubmed: 4860352
J Eval Clin Pract. 2019 Dec;25(6):943-954
pubmed: 31313412
Clin Trials. 2015 Oct;12(5):436-41
pubmed: 26374676
Clin Trials. 2020 Jun;17(3):253-263
pubmed: 32367741
Eur J Clin Pharmacol. 2021 Apr;77(4):539-546
pubmed: 33106910
Dialogues Clin Neurosci. 2011;13(2):217-24
pubmed: 21842619
BMJ Open. 2017 Sep 03;7(9):e017887
pubmed: 28871028
Trials. 2018 Aug 23;19(1):448
pubmed: 30134950
Eur J Clin Pharmacol. 2020 Aug;76(8):1093-1102
pubmed: 32447436
J Clin Epidemiol. 2018 Nov;103:10-21
pubmed: 29966732
J Clin Epidemiol. 2020 Sep;125:30-37
pubmed: 32422248
BMJ Open. 2017 Oct 5;7(10):e015997
pubmed: 28982811
BMC Med Ethics. 2018 Feb 27;19(1):14
pubmed: 29482537
J Clin Epidemiol. 2017 Aug;88:7-13
pubmed: 28549929
Learn Health Syst. 2017 Nov 02;2(1):e10044
pubmed: 31245573
Clin Trials. 2018 Feb;15(1):21-24
pubmed: 29250989
BMC Health Serv Res. 2021 Feb 17;21(1):156
pubmed: 33596906
Trials. 2009 Jun 03;10:37
pubmed: 19493350
BMJ. 2008 Nov 11;337:a2390
pubmed: 19001484
J Clin Epidemiol. 2016 Feb;70:26-37
pubmed: 26226103
JAMA. 2015 Mar 3;313(9):895-6
pubmed: 25591061
J Clin Epidemiol. 2009 May;62(5):479-84
pubmed: 18468856
J Clin Epidemiol. 2020 Oct;126:202-206
pubmed: 32565215
BMJ. 2015 May 08;350:h2147
pubmed: 25956159

Auteurs

Stuart G Nicholls (SG)

Clinical Epidemiology Program, Ottawa Hospital Research Institute (OHRI). Electronic address: snicholls@ohri.ca.

Kelly Carroll (K)

Clinical Epidemiology Program, Ottawa Hospital Research Institute (OHRI).

Spencer Phillips Hey (SP)

CEO, Prism Analytic Technologies; Cambridge, MA.

Merrick Zwarenstein (M)

Centre for Studies in Family Medicine, Department of Family Medicine, Schulich School of Medicine & Dentistry, Western University, 1151 Richmond Street, London, Ontario, Canada, N6A 3K7; Department of Family Medicine, Western University, London, Canada; Schulich School of Medicine & Dentistry, Western University, London, Canada.

Jennifer Zhe Zhang (JZ)

School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.

Hayden P Nix (HP)

Schulich School of Medicine & Dentistry, Western University, London, Canada.

Jamie C Brehaut (JC)

Clinical Epidemiology Program, Ottawa Hospital Research Institute (OHRI); School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.

Joanne E McKenzie (JE)

School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Road, Melbourne, Victoria 3004, Australia.

Steve McDonald (S)

School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Road, Melbourne, Victoria 3004, Australia.

Charles Weijer (C)

Department of Medicine, Western University, London, Canada; Department of Epidemiology and Biostatistics, Western University, London, Canada; Department of Philosophy, Western University, London, Canada.

Dean A Fergusson (DA)

Clinical Epidemiology Program, Ottawa Hospital Research Institute (OHRI); School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada; Department of Medicine, University of Ottawa, Ottawa, Canada.

Monica Taljaard (M)

Clinical Epidemiology Program, Ottawa Hospital Research Institute (OHRI); School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH